Illumina, Inc. completed its acquisition of Standard BioTools’ assets, specifically SomaLogic and Sengenics, on January 30, 2026, for $350 million, plus potential additional payments of up to $75 million.
AI Assistant
ILLUMINA INC
2026
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.